Percutaneous vertebroplasty

Series
Spine
Status
Ongoing
Date
Number of report
058

Ask the expert

(we accept only company emails)

The report presents a summary of reimbursement situation for percutaneous vertebroplasty.

Report includes information about reimbursement for percutaneous vertebroplasty in day case and hospital settings.

The following indications are considered:

  • osteoporosis with pathological fracture;
  • secondary malignant neoplasm of spine (breast cancer).

The only reimbursement within public / statutory health insurance systems is considered.

Report includes essential information about reimbursement and national funding, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland

Manufacturers of devices for percutaneous vertebroplasty include:

  • Alphatec Spine (Osseofix)
  • Benvenue Medical (Luna 3D, Orbit)
  • Biopsybell Medica (Vertebrosteel)
  • BM Korea Medical (Guardian-OP)
  • DePuy Synthes (Vertecem)
  • G21 (V-Kit 01)
  • Globus Medical (Allocate)
  • iMedicom (IVP-KIT)
  • Joimax (Spasy)
  • Maxxspine (Vertebroplasty-Set)
  • Medtronic (Kyphon V)
  • Merit Medical (StabiliT, Osseoflex)
  • Osteomed (Vertebroplasty Kit)
  • STERYLAB (Vertoplast)
  • Stryker Corporation (VertePort X4, VertePort, PCD, AutoPlex)
  • Taeyeon Medical (PCD System)
  • Vexim (Spine Jack)

Table of content is not available at the moment. Report is still ongoing.

18

Apr 2019

The report presents a summary of reimbursement situation for balloon kyphoplasty. The following indications will be considered: osteoporosis with pathological fracture, secondary malignant neoplasm of spine (breast cancer). The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

21

Mar 2019

The report presents a summary of reimbursement situation for percutaneous vertebroplasty. The following indications are considered: osteoporosis with pathological fracture, secondary malignant neoplasm of spine (breast cancer). The analysis covers procedure coding, payment mechanism, reimbursement tariffs and policy restrictions in 11 EU countries including Austria, Belgium, Denmark, England, France, Germany, Italy, the Netherlands, Norway, Sweden and Switzerland.

Read more

16

Jan 2019

The Federal Statistics Office has published, in late December 2018, the changes regarding procedure coding that would come into force in January 2019. The changes concern CAR-T cell therapy and intervertebral arthrodesis devices, among other treatment methods. Besides the changes implemented, the list of all requested changes in 2018 was published.

Read more

27

Nov 2018

New national clinical guideline for spinal stabilization in adults with trauma contains a number of recommendations for stabilizing the spine in adults who have been exposed to a trauma.

Read more

26

Sep 2018

In the second half of July, the National Institute for Health and Care Excellence (NICE) published five new Interventional Procedure Guidance for low-intensity pulsed ultrasound to promote healing of fresh fractures at low risk of non-healing, fresh fractures at high risk of non-healing, superior capsular augmentation for massive rotator cuff tears, transaxial interbody lumbosacral fusion for severe chronic low back pain and two new Medtech Innovation Briefings for remote ECG interpretation consultancy services for cardiovascular disease and mechanical thrombectomy devices for acute ischaemic stroke.

Read more

21

Sep 2017

Ludwig Boltzmann Institute for Health Technology Assessment (LBI-HTA) released results of a re-evaluation of percutaneous volume reduction of the intervertebral disk with a focus on chemolucleolysis. Based on current evidence, chemonucleolysis was recommended for inclusion into health benefit catalogue in Austria while percutaneous nucleotomy and percutaneous laser disc decompression were currently not recommended.

Read more

06

Jul 2017

An assessment was initiated earlier this year. The Institute will evaluate compliance of dynamic fusion in lumbar spondylosis with the state of science and practice.

Read more

27

Jun 2017

Assessments were directed by national HTA body AGENAS. They cover renal denervation for hypertension, next generation sequencing in oncology, robotic surgery, sling operation for urinary incontinence and vertebral disc replacement.

Read more

22

Jun 2017

The Clinical Coding and Schedule Development Group develops and maintains procedural and diagnostics nomenclature for private payers in England. Several codes were added to both procedural and diagnostic Schedules, including procedures on spine and endoscopy procedure.

Read more

31

May 2017

French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of 9 medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May and April. Among others decision included MRI compatible and recharge free spinal cord stimulation devices, resorbable plates for osteosynthesis.

Read more

22

May 2017

Belgian Health Care Knowledge Center has released new clinical guidelines for evaluation and management of low back pain without serious underlying cause and radicular pain (including neurogenic claudication). It has number of implications for medical procedures, including transcutaneous electrical nerve stimulation, radiofrequency denervation, disk replacement, spine fusion and other.

Read more
(we accept only company emails)